ConforMIS, a Burlington, Mass.-based medical device company focused on personalized knee replacement implants, has raised $89 million in Series E round funding with the potential to receive more in the future, according to a company news release.
The company reported doubling revenues in 2011 and plans to use the new funds to support ongoing sales and marketing expansion, research and development for new product lines and building out of manufacturing infrastructure.
"This latest round of funding provides us with the resources to aggressively grow our business and invest in our scale up," said CEO and chairman of the board Philipp Lang, MD, MBA. "It also provides us with the resources to pursue strategic initiatives in technology and intellectual property expansion."
Related Articles on Orthopedic Devices:
NuVasive Shares Rise After Judge's Ruling
Zimmer's 2.9% Sales Increase Driven by Foreign Markets
Interventional Spine Receives FDA Clearance for Spine Device
"This latest round of funding provides us with the resources to aggressively grow our business and invest in our scale up," said CEO and chairman of the board Philipp Lang, MD, MBA. "It also provides us with the resources to pursue strategic initiatives in technology and intellectual property expansion."
Related Articles on Orthopedic Devices:
NuVasive Shares Rise After Judge's Ruling
Zimmer's 2.9% Sales Increase Driven by Foreign Markets
Interventional Spine Receives FDA Clearance for Spine Device